The HDAC inhibitor SAHA has been found to decrease HIF1α levels in tumor cell lines via direct acetylation of heat shock protein 90 (Hip90), a HIFα chaperone protein, using HDAC6 [171]. Here, HIF1A is linked to neoplasm.